Mirae Asset Global Investments Co., Ltd. Moderna, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 58,673 shares of MRNA stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,673
Previous 52,028
12.77%
Holding current value
$1.61 Million
Previous $1.47 Million
9.77%
% of portfolio
0.01%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
859Shares Held
266MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$703 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$607 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$475 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$244 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...